GE HealthCare Technologies Inc. (NASDAQ:GEHC) CEO Sells $1,649,916.39 in Stock

GE HealthCare Technologies Inc. (NASDAQ:GEHC) CEO Jan Makela sold 20,227 shares of the company’s stock in a transaction dated Monday, May 13th. The shares were sold at an average price of $81.57, for a total value of $1,649,916.39. Following the completion of the transaction, the chief executive officer now owns 63,348 shares in the company, valued at approximately $5,167,296.36. The sale was disclosed in a filing with the SEC, which is available through the SEC website.

Jan Makela also recently made the following trade(s):

• On Wednesday, May 15th, Jan Makela sold 66,955 shares of GE HealthCare Technologies stock. The shares were sold at an average price of $81.54, for a total transaction of $5,459,510.70.

GE HealthCare Technologies Price Performance

Shares of GE HealthCare Technologies stock opened at $81.31 on Friday. The company has a current ratio of 1.06, a quick ratio of 0.83 and a debt-to-equity ratio of 1.11. The firm has a fifty day simple moving average of $86.31 and a 200-day simple moving average of $79.95. The stock has a market capitalization of $37.11 billion, a price-to-earnings ratio of 23.77, a PEG ratio of 2.91 and a beta of 1.26. GE HealthCare Technologies Inc. has a 1-year low of $62.35 and a 1-year high of $94.50.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Tuesday, April 30th. The company reported $0.90 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.90. The firm had revenue of $4.65 billion during the quarter, compared to analyst estimates of $4.80 billion. GE HealthCare Technologies had a net margin of 8.05% and a return on equity of 25.32%. The business’s revenue was down 1.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.85 EPS. On average, sell-side analysts expect that GE HealthCare Technologies Inc. will post 4.27 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th were issued a $0.03 dividend. This represents a $0.12 dividend on an annualized basis and a yield of 0.15%. The ex-dividend date was Thursday, April 18th. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.51%.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the business. BNP Paribas acquired a new stake in shares of GE HealthCare Technologies in the first quarter worth $30,000. Rise Advisors LLC boosted its holdings in GE HealthCare Technologies by 241.4% in the 1st quarter. Rise Advisors LLC now owns 338 shares of the company’s stock valued at $31,000 after purchasing an additional 239 shares during the period. Riverview Trust Co acquired a new stake in GE HealthCare Technologies in the 1st quarter worth $31,000. Annapolis Financial Services LLC increased its holdings in shares of GE HealthCare Technologies by 171.9% during the 1st quarter. Annapolis Financial Services LLC now owns 348 shares of the company’s stock worth $32,000 after purchasing an additional 220 shares during the period. Finally, First Command Advisory Services Inc. raised its position in shares of GE HealthCare Technologies by 36,900.0% during the third quarter. First Command Advisory Services Inc. now owns 370 shares of the company’s stock valued at $25,000 after buying an additional 369 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the stock. UBS Group raised shares of GE HealthCare Technologies from a “sell” rating to a “neutral” rating and lifted their target price for the company from $66.00 to $88.00 in a research note on Monday, February 12th. Morgan Stanley boosted their target price on GE HealthCare Technologies from $74.00 to $86.00 and gave the company an “equal weight” rating in a research note on Monday, February 12th. HSBC assumed coverage on GE HealthCare Technologies in a research note on Thursday, February 15th. They set a “buy” rating and a $100.00 price target for the company. Evercore ISI boosted their price target on GE HealthCare Technologies from $93.00 to $100.00 and gave the company an “outperform” rating in a research note on Thursday, April 4th. Finally, Mizuho cut their price objective on shares of GE HealthCare Technologies from $110.00 to $105.00 and set a “buy” rating on the stock in a research report on Wednesday, May 1st. Four research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and an average price target of $94.80.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.